Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ADVM |
---|---|---|
09:32 ET | 3414 | 6.63 |
09:34 ET | 26105 | 6.8 |
09:36 ET | 300 | 6.89 |
09:39 ET | 700 | 6.83 |
09:43 ET | 99108 | 6.9021 |
09:45 ET | 6373 | 6.925 |
09:48 ET | 19903 | 6.92 |
09:50 ET | 200 | 6.9 |
09:54 ET | 12700 | 6.82 |
09:56 ET | 2300 | 6.85 |
09:57 ET | 1200 | 6.85 |
09:59 ET | 1718 | 6.89 |
10:01 ET | 2000 | 6.88 |
10:03 ET | 507 | 6.8531 |
10:06 ET | 433 | 6.875 |
10:10 ET | 814 | 6.95 |
10:12 ET | 6400 | 6.9723 |
10:14 ET | 300 | 7 |
10:19 ET | 100 | 6.975 |
10:21 ET | 1423 | 7.02 |
10:24 ET | 100 | 6.9595 |
10:30 ET | 376 | 7.02 |
10:33 ET | 664 | 7.02 |
10:35 ET | 600 | 7 |
10:37 ET | 1200 | 6.97 |
10:42 ET | 200 | 6.945 |
10:48 ET | 100 | 6.9 |
10:50 ET | 100 | 6.9 |
10:51 ET | 100 | 6.9 |
10:53 ET | 100 | 6.9 |
10:55 ET | 100 | 6.89 |
11:00 ET | 2400 | 6.915 |
11:02 ET | 464 | 6.9 |
11:04 ET | 100 | 6.85 |
11:06 ET | 100 | 6.85 |
11:08 ET | 100 | 6.85 |
11:09 ET | 200 | 6.85 |
11:11 ET | 100 | 6.85 |
11:15 ET | 100 | 6.86 |
11:18 ET | 200 | 6.85 |
11:20 ET | 200 | 6.86 |
11:22 ET | 100 | 6.85 |
11:24 ET | 100 | 6.86 |
11:26 ET | 100 | 6.85 |
11:27 ET | 100 | 6.85 |
11:29 ET | 100 | 6.85 |
11:31 ET | 100 | 6.85 |
11:33 ET | 900 | 6.85 |
11:42 ET | 500 | 6.845 |
11:45 ET | 100 | 6.82 |
11:47 ET | 277 | 6.84 |
11:49 ET | 100 | 6.82 |
11:51 ET | 900 | 6.86 |
11:58 ET | 600 | 6.85 |
12:05 ET | 100 | 6.85 |
12:09 ET | 100 | 6.85 |
12:12 ET | 517 | 6.84 |
12:14 ET | 100 | 6.84 |
12:16 ET | 300 | 6.84 |
12:18 ET | 200 | 6.845 |
12:20 ET | 600 | 6.77 |
12:21 ET | 100 | 6.73 |
12:23 ET | 988 | 6.73 |
12:25 ET | 97825 | 6.75 |
12:27 ET | 298624 | 6.67 |
12:30 ET | 300 | 6.695 |
12:34 ET | 201 | 6.73 |
12:36 ET | 500 | 6.675 |
12:38 ET | 100 | 6.64 |
12:39 ET | 200 | 6.62 |
12:41 ET | 400 | 6.635 |
12:43 ET | 100 | 6.66 |
12:45 ET | 200 | 6.67 |
12:50 ET | 100 | 6.62 |
12:56 ET | 600 | 6.6 |
12:57 ET | 300 | 6.63 |
12:59 ET | 571 | 6.64 |
01:03 ET | 214 | 6.62 |
01:06 ET | 100 | 6.63 |
01:10 ET | 1058 | 6.63 |
01:12 ET | 608 | 6.65 |
01:14 ET | 500 | 6.62 |
01:15 ET | 801 | 6.65 |
01:17 ET | 100 | 6.63 |
01:24 ET | 100 | 6.65 |
01:28 ET | 100 | 6.65 |
01:30 ET | 300 | 6.67 |
01:35 ET | 400 | 6.65 |
01:39 ET | 500 | 6.655 |
01:42 ET | 400 | 6.67 |
01:44 ET | 4600 | 6.67 |
01:48 ET | 704 | 6.725 |
01:50 ET | 1898 | 6.71 |
01:51 ET | 1389 | 6.74 |
01:53 ET | 45720 | 6.75 |
01:55 ET | 100 | 6.74 |
01:57 ET | 100 | 6.76 |
02:00 ET | 100000 | 6.755 |
02:02 ET | 1000 | 6.75 |
02:04 ET | 243 | 6.74 |
02:06 ET | 1480 | 6.77 |
02:09 ET | 100 | 6.75 |
02:13 ET | 300 | 6.79 |
02:15 ET | 100 | 6.77 |
02:18 ET | 100 | 6.78 |
02:22 ET | 400 | 6.79 |
02:24 ET | 300 | 6.8 |
02:26 ET | 4083 | 6.83 |
02:27 ET | 200 | 6.84 |
02:29 ET | 600 | 6.81 |
02:33 ET | 100 | 6.81 |
02:36 ET | 300 | 6.82 |
02:38 ET | 600 | 6.82 |
02:40 ET | 600 | 6.85 |
02:42 ET | 34325 | 6.865 |
02:44 ET | 88400 | 6.89 |
02:45 ET | 12006 | 6.895 |
02:47 ET | 100 | 6.87 |
02:49 ET | 300 | 6.87 |
02:51 ET | 100 | 6.86 |
02:54 ET | 200 | 6.86 |
02:56 ET | 200 | 6.88 |
03:00 ET | 200 | 6.86 |
03:02 ET | 1200 | 6.89 |
03:03 ET | 100 | 6.88 |
03:07 ET | 300 | 6.84 |
03:09 ET | 651 | 6.82 |
03:12 ET | 900 | 6.85 |
03:16 ET | 200 | 6.84 |
03:18 ET | 100 | 6.82 |
03:20 ET | 300 | 6.82 |
03:21 ET | 609 | 6.82 |
03:23 ET | 1060 | 6.84 |
03:25 ET | 500 | 6.85 |
03:27 ET | 300 | 6.86 |
03:30 ET | 651 | 6.87 |
03:32 ET | 100 | 6.865 |
03:34 ET | 1400 | 6.81 |
03:36 ET | 3800 | 6.75 |
03:38 ET | 870 | 6.75 |
03:39 ET | 600 | 6.73 |
03:41 ET | 870 | 6.71 |
03:43 ET | 3694 | 6.69 |
03:45 ET | 300 | 6.71 |
03:48 ET | 301 | 6.71 |
03:50 ET | 200 | 6.69 |
03:54 ET | 3100 | 6.73 |
03:56 ET | 26580 | 6.8 |
03:57 ET | 1900 | 6.8 |
03:59 ET | 11914 | 6.82 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Adverum Biotechnologies Inc | 141.9M | -0.9x | --- |
Century Therapeutics Inc | 136.4M | -0.8x | --- |
Inovio Pharmaceuticals Inc | 147.0M | -1.1x | --- |
Context Therapeutics Inc | 141.7M | -1.8x | --- |
Immunic Inc | 143.2M | -1.1x | --- |
Tenaya Therapeutics Inc | 140.4M | -1.2x | --- |
Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company. The Company discovers and develops gene therapy product candidates that provides durable efficacy by inducing sustained expression of a therapeutic protein. Its lead product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable levels of aflibercept associated with a sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) IVT injections. Ixo-vec is being developed for the treatment of patients with wet age-related macular degeneration. Its second product candidate, ADVM-062 (AAV.7m8-L-opsin), is a gene therapy product candidate being developed to treat patients suffering from blue cone monochromacy (BCM) via a single IVT injection. It also developing an early-stage pipeline of gene therapy programs.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $141.9M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 20.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.02 |
EPS | $-7.99 |
Book Value | $8.23 |
P/E Ratio | -0.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.